Shp-2 is implicated in several tyrosine kinase receptor signaling pathways.
This phosphotyrosine phosphatase is composed of a catalytic domain in its
C-terminus and two SH2 domains in its N-terminus. Shp-2 becomes activated u
pon binding through one or both SH2 domains to tyrosine phosphorylated mole
cules such as Shc or insulin receptor substrates.
We were interested in finding a new molecule(s), tyrosine phosphorylated by
the insulin receptor ((IR), that could interact with Shp-2. To do so, we s
creened a human placenta complementary DNA (cDNA) Library with the SH2 doma
in-containing part of Shp-2 using a modified yeast two-hybrid system. In th
is system we induce or repress the expression of a constitutive active IR p
-subunit. When expressed, IR phosphorylates proteins produced from the libr
ary that can then associate with Shp-2.
Using this approach, we isolated FRS2 as a potential target for tyrosine ph
osphorylation by the IR. After cloning the entire cDNA, we found that 1) in
the yeast two-hybrid system, FRS2 interacts with Shp-2 in a fashion depend
ent on the presence of the IR; and 2) in the PC12/IR cell-line, insulin lea
ds to an increase in FRS2 association with the phosphatase.
We next wanted to determine whether FRS2 could be a direct substrate for IR
. In an in vitro kinase assay we found that wheat-germ agglutinin-purified
IR phosphorylates glutathione-S-transferase-FRS2 fusion protein. Finally, i
n intact cells we show that insulin stimulates tyrosine phosphorylation of
endogenous FRS2.
In summary, by screening a two-hybrid cDNA library, we have isolated FRS2 a
s a possible substrate for IR. We found that IR can directly phosphorylate
FRS2. Moreover, in intact cells insulin stimulates tyrosine phosphorylation
of FRS2 and its subsequent association with Shp-2. Taken together these re
sults suggest that FRS2 could participate in insulin signaling by recruitin
g Shp-2 and, hence, could function as a docking molecule similar to insulin
receptor substrate proteins.